{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T20:05:14Z","timestamp":1725998714693},"publisher-location":"Singapore","reference-count":84,"publisher":"Springer Singapore","isbn-type":[{"type":"print","value":"9789811314346"},{"type":"electronic","value":"9789811314353"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-981-13-1435-3_17","type":"book-chapter","created":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T07:48:45Z","timestamp":1541144925000},"page":"369-391","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Muscular Atrophy in Cardiovascular Disease"],"prefix":"10.1007","author":[{"given":"Isadora Rebolho","family":"Sisto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melina","family":"Hauck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo Della M\u00e9a","family":"Plentz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,3]]},"reference":[{"key":"17_CR1","unstructured":"WHO (2011) Global atlas on cardiovascular disease prevention and control. In: Assess. \nhttp:\/\/www.who.int\/cardiovascular_diseases\/publications\/atlas_cvd\/en\/"},{"key":"17_CR2","doi-asserted-by":"publisher","unstructured":"Okoshi MP, Romeiro FG, Paiva SAR, Okoshi K (2013) Heart failure-induced Cachexia. Arq Bras Cardiol. \nhttps:\/\/doi.org\/10.5935\/abc.20130060","DOI":"10.5935\/abc.20130060"},{"key":"17_CR3","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1590\/S0103-51502011000300010","volume":"24","author":"TS P\u00edcoli da","year":"2011","unstructured":"da P\u00edcoli TS, de Figueiredo LL, Patrizzi LJ (2011) Sarcopenia e envelhecimento. Fisioter em Mov 24:455\u2013462. \nhttps:\/\/doi.org\/10.1590\/S0103-51502011000300010","journal-title":"Fisioter em Mov"},{"key":"17_CR4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/jcsm.12068","volume":"7","author":"N Scherbakov","year":"2016","unstructured":"Scherbakov N, Knops M, Ebner N et al (2016) Evaluation of C-terminal Agrin fragment as a marker of muscle wasting in patients after acute stroke during early rehabilitation. J Cachexia Sarcopenia Muscle 7:60\u201367. \nhttps:\/\/doi.org\/10.1002\/jcsm.12068","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"17_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cger.2010.08.009.The","volume":"27","author":"Q-L Xue","year":"2011","unstructured":"Xue Q-L (2011) The frailty syndrome: definition and natural history. Clin Geriatr Med 27:1\u201315. \nhttps:\/\/doi.org\/10.1016\/j.cger.2010.08.009.The","journal-title":"Clin Geriatr Med"},{"key":"17_CR6","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jamda.2014.12.007","volume":"16","author":"N Scherbakov","year":"2015","unstructured":"Scherbakov N, Sandek A, Doehner W (2015) Stroke-related sarcopenia: specific characteristics. J Am Med Dir Assoc 16:272\u2013276. \nhttps:\/\/doi.org\/10.1016\/j.jamda.2014.12.007","journal-title":"J Am Med Dir Assoc"},{"key":"17_CR7","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/ageing\/afq034","volume":"39","author":"AJ Cruz-Jentoft","year":"2010","unstructured":"Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al (2010) Sarcopenia: European consensus on definition and diagnosis. Age Ageing 39:412\u2013423. \nhttps:\/\/doi.org\/10.1093\/ageing\/afq034","journal-title":"Age Ageing"},{"key":"17_CR8","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s12603-016-0743-9","volume":"21","author":"H Harada","year":"2016","unstructured":"Harada H, Kai H, Niiyama H et al (2016) Effectiveness of cardiac rehabilitation for prevention and treatment of sarcopenia in patients with cardiovascular disease\u00a0\u2013 a retrospective cross-sectional analysis. J Nutr Heal Aging 21:449\u2013456. \nhttps:\/\/doi.org\/10.1007\/s12603-016-0743-9","journal-title":"J Nutr Heal Aging"},{"key":"17_CR9","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1093\/eurheartj\/ehw008","volume":"37","author":"M Valentova","year":"2016","unstructured":"Valentova M, Von Haehling S, Bauditz J et\u00a0al (2016) Intestinal congestion and right ventricular dysfunction: a link with appetite loss, inflammation, and cachexia in chronic heart failure. Eur Heart J 37:1684\u20131691. \nhttps:\/\/doi.org\/10.1093\/eurheartj\/ehw008","journal-title":"Eur Heart J"},{"key":"17_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0140-6736(11)60739-3.09-2015-VYT-13-BR-J","volume":"101","author":"HT Xavier","year":"2013","unstructured":"Xavier HT, Izar MC, Faria Neto JR et al (2013) V diretriz brasileira de da Aterosclerose V D iretriz B rasileira de D islipidemias e P reven\u00e7\u00e3o. Arq Bras Cardiol 101:1\u201320. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(11)60739-3.09-2015-VYT-13-BR-J","journal-title":"Arq Bras Cardiol"},{"key":"17_CR11","unstructured":"Gersh B, Braunwald E, Bonow R (2000) Chronic coronary artery disease. In: Heart disease: a textbook of cardiovascular medicine. pp 272\u2013363"},{"key":"17_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2015.10.044","volume":"67","author":"L Anderson","year":"2016","unstructured":"Anderson L, Oldridge N, Thompson DR et al (2016) Exercise-based cardiac rehabilitation for coronary heart disease. J Am Coll Cardiol 67:1\u201312. \nhttps:\/\/doi.org\/10.1016\/j.jacc.2015.10.044","journal-title":"J Am Coll Cardiol"},{"key":"17_CR13","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1080\/00207454.2017.1280793","volume":"127","author":"A Gofir","year":"2017","unstructured":"Gofir A, Mulyono B, Sutarni S (2017) Hyperglycemia as a prognosis predictor of length of stay and functional outcomes in patients with acute ischemic stroke. Int J Neurosci 127:923\u2013929. \nhttps:\/\/doi.org\/10.1080\/00207454.2017.1280793","journal-title":"Int J Neurosci"},{"key":"17_CR14","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.ncl.2008.06.001","volume":"26","author":"FD Testai","year":"2008","unstructured":"Testai FD, Aiyagari V (2008) Acute hemorrhagic stroke pathophysiology and medical interventions: blood pressure control, management of anticoagulant-associated brain hemorrhage and general management principles. Neurol Clin 26:963\u2013985. \nhttps:\/\/doi.org\/10.1016\/j.ncl.2008.06.001","journal-title":"Neurol Clin"},{"key":"17_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/ijlh.12426","volume":"293","author":"R Motyer","year":"2018","unstructured":"Motyer R, Asadi H, Nicholson JTP, Kok HK (2018) Current evidence for endovascular therapy in stroke and remaining uncertainties (R1). J Intern Med 293:2\u201315. \nhttps:\/\/doi.org\/10.1111\/ijlh.12426","journal-title":"J Intern Med"},{"key":"17_CR16","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s13539-013-0103-0","volume":"4","author":"M Knops","year":"2013","unstructured":"Knops M, Werner CG, Scherbakov N et al (2013) Investigation of changes in body composition, metabolic profile and skeletal muscle functional capacity in ischemic stroke patients: the rationale and design of the Body Size in Stroke Study (BoSSS). J Cachexia Sarcopenia Muscle 4:199\u2013207. \nhttps:\/\/doi.org\/10.1007\/s13539-013-0103-0","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"17_CR17","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1177\/1545968311408920.Atrophy","volume":"25","author":"AS Ryan","year":"2011","unstructured":"Ryan AS, Buscemi A, Forrester L et al (2011) Atrophy and intramuscular fat in specific muscles of the thigh: associated weakness and hyperinsulinemia in stroke survivors. Neurorehabil Neural Repair 25:865\u2013872. \nhttps:\/\/doi.org\/10.1177\/1545968311408920.Atrophy","journal-title":"Neurorehabil Neural Repair"},{"key":"17_CR18","unstructured":"WHO (2011) World report on disability. In: Assess. http:\/\/apps.who.int\/iris\/bitstream\/10665\/70670\/1\/WHO_NMH_VIP_11.01_eng.pdf"},{"key":"17_CR19","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1037\/a0038432.Latino","volume":"98","author":"AS Ryan","year":"2017","unstructured":"Ryan AS, Ivey FM, Serra MC et al (2017) Sarcopeia and physical function in middle-aged and older stroke survivors. Arch Phys Med Rehabil 98:495\u2013499. \nhttps:\/\/doi.org\/10.1037\/a0038432.Latino","journal-title":"Arch Phys Med Rehabil"},{"key":"17_CR20","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1161\/STROKEAHA.116.013794","volume":"48","author":"IA Deijle","year":"2017","unstructured":"Deijle IA, Van Schaik SM, Van Wegen EEH et al (2017) Lifestyle interventions to prevent cardiovascular events after stroke and transient ischemic attack. Stroke 48:174\u2013179. \nhttps:\/\/doi.org\/10.1161\/STROKEAHA.116.013794","journal-title":"Stroke"},{"key":"17_CR21","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1080\/10749357.2017.1292720.Skeletal","volume":"24","author":"JL Hunnicutt","year":"2017","unstructured":"Hunnicutt JL, Gregory CM, Sciences H (2017) Skeletal muscle changes following stroke: a systematic review and comparison to healthy individuals. Top Stroke Rehabil 24:463\u2013471. \nhttps:\/\/doi.org\/10.1080\/10749357.2017.1292720.Skeletal","journal-title":"Top Stroke Rehabil"},{"key":"17_CR22","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1161\/STROKEAHA.114.006258","volume":"45","author":"J Springer","year":"2014","unstructured":"Springer J, Schust S, Peske K et al (2014) Catabolic signaling and muscle wasting after acute ischemic stroke in mice: indication for a stroke-specific sarcopenia. Stroke 45:3675\u20133683. \nhttps:\/\/doi.org\/10.1161\/STROKEAHA.114.006258","journal-title":"Stroke"},{"key":"17_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ijcard.2013.10.031","volume":"170","author":"N Scherbakov","year":"2013","unstructured":"Scherbakov N, Von Haehling S, Anker SD et al (2013) Stroke induced sarcopenia: muscle wasting and disability after stroke. Int J Cardiol 170:89\u201394. \nhttps:\/\/doi.org\/10.1016\/j.ijcard.2013.10.031","journal-title":"Int J Cardiol"},{"key":"17_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s13539-011-0024-8","volume":"2","author":"N Scherbakov","year":"2011","unstructured":"Scherbakov N, Doehner W (2011) Sarcopenia or muscle modifications in neurologic diseases: a lexical or patophysiological difference? J Cachexia Sarcopenia Muscle 2:5\u20138. \nhttps:\/\/doi.org\/10.1007\/s13539-011-0024-8","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"17_CR25","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1177\/1538574407311106","volume":"41","author":"II Pipinos","year":"2008","unstructured":"Pipinos II, Judge AR, Selsby JT et al (2008) The myopathy of peripheral arterial occlusive disease: part 1. Functional and histomorphological changes and evidence for mitochondrial dysfunction. Vasc Endovasc Surg 41:481\u2013489. \nhttps:\/\/doi.org\/10.1177\/1538574407311106","journal-title":"Vasc Endovasc Surg"},{"key":"17_CR26","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.jsams.2013.10.251","volume":"17","author":"CD Askew","year":"2014","unstructured":"Askew CD, Parmenter B, Leicht AS et al (2014) Exercise & Sports Science Australia (ESSA) position statement on exercise prescription for patients with peripheral arterial disease and intermittent claudication. J Sci Med Sport 17:623\u2013629. \nhttps:\/\/doi.org\/10.1016\/j.jsams.2013.10.251","journal-title":"J Sci Med Sport"},{"key":"17_CR27","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.advms.2015.03.003","volume":"60","author":"A Zimmermann","year":"2015","unstructured":"Zimmermann A, Senner S, Eckstein HH, Pelisek J (2015) Histomorphological evaluation of atherosclerotic lesions in patients with peripheral artery occlusive disease. Adv Med Sci 60:236\u2013239. \nhttps:\/\/doi.org\/10.1016\/j.advms.2015.03.003","journal-title":"Adv Med Sci"},{"key":"17_CR28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.atherosclerosis.2016.10.039","volume":"255","author":"S Haitjema","year":"2016","unstructured":"Haitjema S, van Haelst STW, de Vries JPPM et al (2016) Time-dependent differences in femoral artery plaque characteristics of peripheral arterial disease patients. Atherosclerosis 255:66\u201372. \nhttps:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.10.039","journal-title":"Atherosclerosis"},{"key":"17_CR29","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jvs.2017.01.051","volume":"66","author":"MN Schieber","year":"2017","unstructured":"Schieber MN, Hasenkamp RM, Pipinos II et al (2017) Muscle strength and control characteristics are altered by peripheral artery disease. J Vasc Surg 66:178\u2013186.e12. \nhttps:\/\/doi.org\/10.1016\/j.jvs.2017.01.051","journal-title":"J Vasc Surg"},{"issue":"2","key":"17_CR30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1177\/1538574408315995","volume":"42","author":"Iraklis I. Pipinos","year":"2008","unstructured":"Pipinos II, Judge AR, Selsby JT, et al (2008) The myopathy of peripheral arterial occlusive disease: part 2. Oxidative stress, neuropathy, and shift in muscle fiber type. Vasc Endovascular Surg:101\u2013112","journal-title":"Vascular and Endovascular Surgery"},{"key":"17_CR31","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.rehab.2011.07.961","volume":"54","author":"A Cousin","year":"2011","unstructured":"Cousin A, Popielarz S, Wieczorek V et al (2011) Impact of a rehabilitation program on muscular strength and endurance in peripheral arterial occlusive disease patients. Ann Phys Rehabil Med 54:429\u2013442. \nhttps:\/\/doi.org\/10.1016\/j.rehab.2011.07.961","journal-title":"Ann Phys Rehabil Med"},{"key":"17_CR32","doi-asserted-by":"publisher","unstructured":"Lane R, Ellis B, Watson L, Leng G (2014) Exercise for intermittent claudication. Cochrane Database Syst Rev: 997\u20131002. \nhttps:\/\/doi.org\/10.2522\/ptj.20100419,91","DOI":"10.2522\/ptj.20100419,91"},{"key":"17_CR33","first-page":"1","volume":"98","author":"EA Bocchi","year":"2012","unstructured":"Bocchi EA, Marcondes-Braga FG, Bacal F et al (2012) Atualiza\u00e7\u00e3o da Diretriz Brasileira de Insufici\u00eancia Card\u00edaca Cr\u00f4nica\u00a0\u2013 2012. Arquivos 98:1\u201333","journal-title":"Arquivos"},{"key":"17_CR34","unstructured":"Ladeira J, Neto R (2012) Principais temas em Cardiologia para resid\u00eancia m\u00e9dica"},{"key":"17_CR35","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.jacc.2013.05.020","volume":"62","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B et al (2013) 2013 ACCF\/AHA guideline for the management of heart failure: executive summary: a report of the American college of cardiology foundation\/american heart association task force on practice guidelines. J Am Coll Cardiol 62:1495\u20131539. \nhttps:\/\/doi.org\/10.1016\/j.jacc.2013.05.020","journal-title":"J Am Coll Cardiol"},{"key":"17_CR36","doi-asserted-by":"publisher","unstructured":"Azevedo PS, Polegato BF, Minicucci MF, et al (2016) Cardiac Remodeling: concepts, clinical impact, pathophysiological mechanisms and pharmacologic treatment. Arq Bras Cardiol. doi: \nhttps:\/\/doi.org\/10.5935\/abc.20160005","DOI":"10.5935\/abc.20160005"},{"key":"17_CR37","doi-asserted-by":"publisher","unstructured":"Okoshi MP, Capalbo RV, Romeiro FG, Okoshi K (2016) Cardiac cachexia: perspectives for prevention and treatment. Arq Bras Cardiol:1\u20137. \nhttps:\/\/doi.org\/10.5935\/abc.20160142","DOI":"10.5935\/abc.20160142"},{"key":"17_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1113\/jphysiol.2003.055095","volume":"555","author":"R Ventura-Clapier","year":"2004","unstructured":"Ventura-Clapier R, Garnier A, Veksler V (2004) Energy metabolism in heart failure. J Physiol 555:1\u201313. \nhttps:\/\/doi.org\/10.1113\/jphysiol.2003.055095","journal-title":"J Physiol"},{"key":"17_CR39","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/S0735-1097(96)00556-6","volume":"29","author":"D Mancini","year":"1997","unstructured":"Mancini D, Donchez L, Levine S (1997) Acute unloading of the work of breathing extends exercise duration in patients with heart failure. J Am Coll Cardiol 29:590\u2013596. \nhttps:\/\/doi.org\/10.1016\/S0735-1097(96)00556-6","journal-title":"J Am Coll Cardiol"},{"key":"17_CR40","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1161\/CIRCULATIONAHA.107.188965","volume":"117","author":"DD Schocken","year":"2008","unstructured":"Schocken DD, Benjamin EJ, Fonarow GC et al (2008) Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 117:2544\u20132565. \nhttps:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.188965","journal-title":"Circulation"},{"key":"17_CR41","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1093\/eurjhf\/hfp029","volume":"11","author":"F Najafi","year":"2009","unstructured":"Najafi F, Jamrozik K, Dobson AJ (2009) Understanding the \u201cepidemic of heart failure\u201d: a systematic review of trends in determinants of heart failure. Eur J Heart Fail 11:472\u2013479. \nhttps:\/\/doi.org\/10.1093\/eurjhf\/hfp029","journal-title":"Eur J Heart Fail"},{"key":"17_CR42","doi-asserted-by":"publisher","first-page":"e391","DOI":"10.1161\/CIRCULATIONAHA.109.192065","volume":"119","author":"SA Hunt","year":"2009","unstructured":"Hunt SA, Abraham WT, Chin MH et al (2009) 2009 focused update incorporated into the ACC\/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in adults: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119:e391\u2013e479. \nhttps:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.192065","journal-title":"Circulation"},{"key":"17_CR43","unstructured":"da Sa\u00fade M (2008) Datasus: mortalidade\u00a0\u2013 1996 a 2012, pela CID-10\u00a0\u2013 Brasil. In: Assess. \nhttp:\/\/tabnet.datasus.gov.br\/cgi\/deftohtm.exe?sim\/cnv\/obt10uf.def"},{"key":"17_CR44","doi-asserted-by":"publisher","unstructured":"de Albuquerque DC, de Souza Neto JD, Bacal F et al (2015) I Brazilian registry of heart failure\u00a0\u2013 clinical aspects, care quality and hospitalization outcomes. Arq Bras Cardiol. \nhttps:\/\/doi.org\/10.5935\/abc.20150031","DOI":"10.5935\/abc.20150031"},{"key":"17_CR45","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1161\/CIR.0000000000000366","volume":"133","author":"D Mozaffarian","year":"2016","unstructured":"Mozaffarian D, Benjamin EJ, Go AS et al (2016) Executive summary: heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation 133:447\u2013454. \nhttps:\/\/doi.org\/10.1161\/CIR.0000000000000366","journal-title":"Circulation"},{"key":"17_CR46","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/eurheartj\/ehs381","volume":"34","author":"S F\u00fclster","year":"2013","unstructured":"F\u00fclster S, Tacke M, Sandek A et al (2013) Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF). Eur Heart J 34:512\u2013519. \nhttps:\/\/doi.org\/10.1093\/eurheartj\/ehs381","journal-title":"Eur Heart J"},{"key":"17_CR47","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/ehf2.12027","volume":"2","author":"RT Campbell","year":"2015","unstructured":"Campbell RT, Jackson CE, Wright A et al (2015) Palliative care needs in patients hospitalized with heart failure (PCHF) study: rationale and design. ESC Hear Fail 2:25\u201336. \nhttps:\/\/doi.org\/10.1002\/ehf2.12027","journal-title":"ESC Hear Fail"},{"key":"17_CR48","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.bone.2017.09.008","volume":"105","author":"E Marty","year":"2017","unstructured":"Marty E, Liu Y, Samuel A et al (2017) A review of sarcopenia: enhancing awareness of an increasingly prevalent disease. Bone 105:276\u2013286. \nhttps:\/\/doi.org\/10.1016\/j.bone.2017.09.008","journal-title":"Bone"},{"key":"17_CR49","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00198-016-3520-z","volume":"17","author":"F Buckinx","year":"2017","unstructured":"Buckinx F, Reginster JY, Brunois T et al (2017) Prevalence of sarcopenia in a population of nursing home residents according to their frailty status: results of the SENIOR cohort. J Musculoskelet Neuronal Interact 17:209\u2013217. \nhttps:\/\/doi.org\/10.1007\/s00198-016-3520-z","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"17_CR50","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/ejhf.240","volume":"17","author":"P Rossignol","year":"2015","unstructured":"Rossignol P, Masson S, Barlera S et al (2015) Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI-HF and Val-HeFT trials. Eur J Heart Fail 17:424\u2013433. \nhttps:\/\/doi.org\/10.1002\/ejhf.240","journal-title":"Eur J Heart Fail"},{"key":"17_CR51","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/ageing\/afs194","volume":"42","author":"F Landi","year":"2013","unstructured":"Landi F, Cruz-Jentoft AJ, Liperoti R et al (2013) Sarcopenia and mortality risk in frail olderpersons aged 80 years and older: results from iLSIRENTE study. Age Ageing 42:203\u2013209. \nhttps:\/\/doi.org\/10.1093\/ageing\/afs194","journal-title":"Age Ageing"},{"key":"17_CR52","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/jcsm.12073","volume":"7","author":"JC Brown","year":"2016","unstructured":"Brown JC, Harhay MO, Harhay MN (2016) Sarcopenia and mortality among a population-based sample of community-dwelling older adults. J Cachexia Sarcopenia Muscle 7:290\u2013298. \nhttps:\/\/doi.org\/10.1002\/jcsm.12073","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"17_CR53","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/jcsm.12106","volume":"7","author":"N Ebner","year":"2016","unstructured":"Ebner N, von Haehling S (2016) Unlocking the wasting enigma: highlights from the 8th Cachexia conference. J Cachexia Sarcopenia Muscle 7:90\u201394. \nhttps:\/\/doi.org\/10.1002\/jcsm.12106","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"17_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13539-011-0025-7","volume":"2","author":"K Fearon","year":"2011","unstructured":"Fearon K, Evans WJ, Anker SD (2011) Myopenia-a new universal term for muscle wasting. J Cachexia Sarcopenia Muscle 2:1\u20133. \nhttps:\/\/doi.org\/10.1007\/s13539-011-0025-7","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"17_CR55","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1161\/CIRCULATIONAHA.112.109744","volume":"125","author":"S Haehling Von","year":"2012","unstructured":"Von Haehling S (2012) The muscle in dire straits: mechanisms of wasting in heart failure. Circulation 125:2686\u20132688. \nhttps:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.109744","journal-title":"Circulation"},{"key":"17_CR56","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1378\/chest.115.3.836","volume":"115","author":"SD Anker","year":"1999","unstructured":"Anker SD, Coats AJS (1999) Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation. Chest 115:836\u2013847. \nhttps:\/\/doi.org\/10.1378\/chest.115.3.836","journal-title":"Chest"},{"key":"17_CR57","doi-asserted-by":"publisher","first-page":"622","DOI":"10.7326\/0003-4819-133-8-200010170-00015","volume":"133","author":"DP Kotler","year":"2000","unstructured":"Kotler DP (2000) Cachexia. Ann Intern Med 133:622\u2013634","journal-title":"Ann Intern Med"},{"key":"17_CR58","doi-asserted-by":"publisher","first-page":"615","DOI":"10.11909\/j.issn.1671-5411.2016.07.004","volume":"13","author":"A Collamati","year":"2016","unstructured":"Collamati A, Marzetti E, Calvani R et al (2016) Sarcopenia in heart failure: mechanisms and therapeutic strategies. J Geriatr Cardiol 13:615\u2013624. \nhttps:\/\/doi.org\/10.11909\/j.issn.1671-5411.2016.07.004","journal-title":"J Geriatr Cardiol"},{"key":"17_CR59","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1161\/01.CIR.81.2.518","volume":"81","author":"MJ Sullivan","year":"1990","unstructured":"Sullivan MJ, Green HJ, Cobb FR (1990) Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation 81:518\u2013527. \nhttps:\/\/doi.org\/10.1161\/01.CIR.81.2.518","journal-title":"Circulation"},{"key":"17_CR60","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/01.mco.0000165002.08955.5b","volume":"8","author":"GS Filippatosa","year":"2005","unstructured":"Filippatosa GS, Anker SD, Kremastinos DT (2005) Pathophysiology of peripheral muscle wasting in cardiac cachexia Gerasimos. Curr Opin Clin Nutr Metab Care 8:249\u2013254. \nhttps:\/\/doi.org\/10.1097\/01.mco.0000165002.08955.5b","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"17_CR61","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","volume":"27","author":"WJ Evans","year":"2008","unstructured":"Evans WJ, Morley JE, Argil\u00e9s J et\u00a0al (2008) Cachexia: a new definition. Clin Nutr 27:793\u2013799. \nhttps:\/\/doi.org\/10.1016\/j.clnu.2008.06.013","journal-title":"Clin Nutr"},{"key":"17_CR62","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.ijcard.2014.10.026","volume":"184","author":"S Haehling Von","year":"2015","unstructured":"Von Haehling S, Anker SD (2015) Treatment of cachexia: an overview of recent developments. Int J Cardiol 184:726\u2013742. \nhttps:\/\/doi.org\/10.1016\/j.ijcard.2014.10.026","journal-title":"Int J Cardiol"},{"key":"17_CR63","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0167-5273(02)00245-0","volume":"85","author":"S Haehling Von","year":"2002","unstructured":"Von Haehling S (2002) Cachexia: a therapeutic approach beyond cytokine antagonism. Int J Cardiol 85:173\u2013183","journal-title":"Int J Cardiol"},{"key":"17_CR64","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s13539-011-0052-4","volume":"3","author":"K Sakuma","year":"2012","unstructured":"Sakuma K, Yamaguchi A (2012) Sarcopenia and cachexia: the adaptations of negative regulators of skeletal muscle mass. J Cachexia Sarcopenia Muscle 3:77\u201394. \nhttps:\/\/doi.org\/10.1007\/s13539-011-0052-4","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"17_CR65","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/j.biocel.2005.04.017","volume":"37","author":"PC Schulze","year":"2005","unstructured":"Schulze PC, Sp\u00e4te U (2005) Insulin-like growth factor-1 and muscle wasting in chronic heart failure. Int J Biochem Cell Biol 37:2023\u20132035. \nhttps:\/\/doi.org\/10.1016\/j.biocel.2005.04.017","journal-title":"Int J Biochem Cell Biol"},{"key":"17_CR66","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1016\/j.biocel.2013.04.02","volume":"45","author":"S Haehling Von","year":"2013","unstructured":"Von Haehling S, Steinbeck L, Doehner W et al (2013) Muscle wasting in heart failure: an overview. Int J Biochem Cell Biol 45:2257\u20132265. \nhttps:\/\/doi.org\/10.1016\/j.biocel.2013.04.02","journal-title":"Int J Biochem Cell Biol"},{"key":"17_CR67","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0167-5273(02)00244-9","volume":"85","author":"R Sharma","year":"2002","unstructured":"Sharma R, Anker SD (2002) Cytokines, apoptosis and cachexia: the potential for TNF antagonism. Int J Cardiol 85:161\u2013171. \nhttps:\/\/doi.org\/10.1016\/S0167-5273(02)00244-9","journal-title":"Int J Cardiol"},{"key":"17_CR68","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1161\/CIRCULATIONAHA.111.047381","volume":"125","author":"S Gielen","year":"2012","unstructured":"Gielen S, Sandri M, Kozarez I et al (2012) Exercise training attenuates MuRF-1 expression in the skeletal muscle of patients with chronic heart failure independent of age: the randomized Leipzig exercise intervention in chronic heart failure and aging catabolism study. Circulation 125:2716\u20132727. \nhttps:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.047381","journal-title":"Circulation"},{"key":"17_CR69","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1161\/01.CIR.96.2.526","volume":"96","author":"SD Anker","year":"1997","unstructured":"Anker SD, Chua TP, Ponikowski P et al (1997) Hormonal changes and catabolic\/ anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 96:526\u2013534","journal-title":"Circulation"},{"key":"17_CR70","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1017\/S0952675714000244","volume":"83","author":"J Morley","year":"2006","unstructured":"Morley J, Thomas D, Wilson M-M (2006) Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr 83:735\u2013743. \nhttps:\/\/doi.org\/10.1017\/S0952675714000244","journal-title":"Am J Clin Nutr"},{"key":"17_CR71","doi-asserted-by":"publisher","first-page":"58","DOI":"10.2174\/1871530311313010008","volume":"13","author":"M Zamboni","year":"2013","unstructured":"Zamboni M, Rossi AP, Corzato F et al (2013) Sarcopenia, cachexia and congestive heart failure in the elderly. Endocrine Metab Immune Disord 13:58\u201367","journal-title":"Endocrine Metab Immune Disord"},{"key":"17_CR72","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1007\/s12020-012-9836-3","volume":"43","author":"HM Christensen","year":"2013","unstructured":"Christensen HM, Kistorp C, Schou M et al (2013) Prevalence of cachexia in chronic heart failure and characteristics of body composition and metabolic status. Endocrine 43:626\u2013634. \nhttps:\/\/doi.org\/10.1007\/s12020-012-9836-3","journal-title":"Endocrine"},{"key":"17_CR73","first-page":"BR374","volume":"16","author":"PF Martinez","year":"2010","unstructured":"Martinez PF, Okoshi K, Zornoff LAM et al (2010) Chronic heart failure-induced skeletal muscle atrophy, necrosis, and changes in myogenic regulatory factors. Med Sci Monit 16:BR374\u2013BR383","journal-title":"Med Sci Monit"},{"key":"17_CR74","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ijcard.2008.04.085","volume":"136","author":"AI Larsen","year":"2009","unstructured":"Larsen AI, Skadberg \u00d8, Aarsland T et al (2009) B-type natriuretic peptide is related to histological skeletal muscle abnormalities in patients with chronic heart failure. Int J Cardiol 136:358\u2013362. \nhttps:\/\/doi.org\/10.1016\/j.ijcard.2008.04.085","journal-title":"Int J Cardiol"},{"key":"17_CR75","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0167-5273%2888%2990164-7","volume":"18","author":"DP Lipkin","year":"1988","unstructured":"Lipkin DP, Jones DA, Round JM, Poole-Wilson PA (1988) Abnormalities of skeletal muscle in patients with chronic heart failure. Int J Cardiol 18:187\u2013195. \nhttps:\/\/doi.org\/10.1016\/0167-5273%2888%2990164-7","journal-title":"Int J Cardiol"},{"key":"17_CR76","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1161\/01.CIR.85.5.1751","volume":"85","author":"H Drexler","year":"1992","unstructured":"Drexler H, Riede U, Munzel T et al (1992) Alterations of skeletal muscle in chronic heart failure. Circulation 85:1751\u20131759. \nhttps:\/\/doi.org\/10.1161\/01.CIR.85.5.1751","journal-title":"Circulation"},{"key":"17_CR77","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bmb\/ldq008","volume":"95","author":"MV Narici","year":"2010","unstructured":"Narici MV, Maffulli N (2010) Sarcopenia: characteristics, mechanisms and functional significance. Br Med Bull 95:139\u2013159. \nhttps:\/\/doi.org\/10.1093\/bmb\/ldq008","journal-title":"Br Med Bull"},{"key":"17_CR78","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1016\/S0735-1097%2897%2900381-1","volume":"30","author":"D Harrington","year":"1997","unstructured":"Harrington D, Anker SD, Chua TP et al (1997) Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol 30:1758\u20131764. \nhttps:\/\/doi.org\/10.1016\/S0735-1097%2897%2900381-1","journal-title":"J Am Coll Cardiol"},{"key":"17_CR79","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1113\/expphysiol.2013.076844","volume":"99","author":"PC Brum","year":"2014","unstructured":"Brum PC, Bacurau AV, Cunha TF et al (2014) Skeletal myopathy in heart failure: effects of aerobic exercise training. Exp Physiol 99:616\u2013620. \nhttps:\/\/doi.org\/10.1113\/expphysiol.2013.076844","journal-title":"Exp Physiol"},{"key":"17_CR80","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s13539-014-0152-z","volume":"5","author":"K Josiak","year":"2014","unstructured":"Josiak K, Jankowska EA, Piepoli MF et al (2014) Skeletal myopathy in patients with chronic heart failure: significance of anabolic-androgenic hormones. J Cachexia Sarcopenia Muscle 5:287\u2013296. \nhttps:\/\/doi.org\/10.1007\/s13539-014-0152-z","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"17_CR81","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nrcardio.2017.51","volume":"14","author":"S Haehling Von","year":"2017","unstructured":"Von Haehling S, Ebner N, Dos Santos MR et al (2017) Muscle wasting and cachexia in heart failure: mechanisms and therapies. Nat Rev Cardiol 14:323\u2013341. \nhttps:\/\/doi.org\/10.1038\/nrcardio.2017.51","journal-title":"Nat Rev Cardiol"},{"key":"17_CR82","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1161\/CIRCHEARTFAILURE.114.001615","volume":"8","author":"A Pandey","year":"2015","unstructured":"Pandey A, Parashar A, Kumbhani DJ et al (2015) Exercise training in patients with heart failure and preserved ejection fraction meta-analysis of randomized control trials. Circ Hear Fail 8:33\u201340. \nhttps:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.114.001615","journal-title":"Circ Hear Fail"},{"key":"17_CR83","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/S0735-1097(03)00848-9","volume":"42","author":"S Gielen","year":"2003","unstructured":"Gielen S, Adams V, M\u00f6bius-Winkler S et al (2003) Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. J Am Coll Cardiol 42:861\u2013868. \nhttps:\/\/doi.org\/10.1016\/S0735-1097(03)00848-9","journal-title":"J Am Coll Cardiol"},{"key":"17_CR84","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ijcard.2016.09.127","volume":"225","author":"M Saitoh","year":"2016","unstructured":"Saitoh M, dos Santos MR, Anker M et al (2016) Neuromuscular electrical stimulation for muscle wasting in heart failure patients. Int J Cardiol 225:200\u2013205. \nhttps:\/\/doi.org\/10.1016\/j.ijcard.2016.09.127","journal-title":"Int J Cardiol"}],"container-title":["Advances in Experimental Medicine and Biology","Muscle Atrophy"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-13-1435-3_17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T07:56:15Z","timestamp":1541145375000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-13-1435-3_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9789811314346","9789811314353"],"references-count":84,"URL":"https:\/\/doi.org\/10.1007\/978-981-13-1435-3_17","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2018]]}}}